Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.bajajhealth.com | |
Market Cap | 907.85 Cr. | |
Enterprise Value(EV) | 1,255.14 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 7.71 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 42.69 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 116.55 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.82 | Calculated using Price: 328.95 |
Dividend Yield | 0.30 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.76 Cr. | 27,598,400 Shares |
FaceValue | 5 | |
About Bajaj Healthcare Ltd. | ||
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments. |
1 Day |
|
-0.53% |
1 Week |
|
+1.92% |
1 Month |
|
+7.66% |
3 Month |
|
-2.43% |
6 Month |
|
-21.43% |
1 Year |
|
+2.51% |
2 Year |
|
-2.96% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 22.38 | 19.6 | 10.77 | 17.68 | 20.18 | 18.92 | 38.09 | 24.33 | 12.36 | |
Return on Capital Employed (%) | 19.16 | 18 | 14.52 | 18.25 | 19.75 | 19.47 | 35.91 | 20 | 11.88 | |
Return on Assets (%) | 4.5 | 4.12 | 3.65 | 6.23 | 6.1 | 8.28 | 19.14 | 11.45 | 5.3 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 82 | 89 | 99 | 114 | 129 | 178 | 258 | 328 | 368 | 316 | |
Non Curr. Liab. | 22 | 32 | 28 | 23 | 20 | 27 | 85 | 71 | 98 | 59 | |
Curr. Liab. | 85 | 88 | 93 | 131 | 117 | 138 | 183 | 322 | 436 | 461 | |
Minority Int. | |||||||||||
Equity & Liab. | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 901 | 836 | |
Non Curr. Assets | 110 | 131 | 128 | 129 | 130 | 175 | 267 | 323 | 392 | 268 | |
Curr. Assets | 79 | 78 | 91 | 140 | 137 | 168 | 258 | 398 | 510 | 568 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 189 | 209 | 219 | 268 | 267 | 343 | 526 | 721 | 901 | 836 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 197 | 200 | 207 | 290 | 325 | 410 | 657 | 680 | 673 | 498 | |
Other Income | 0 | 0 | 2 | 2 | 1 | 7 | 7 | 1 | 2 | 3 | |
Total Income | 197 | 201 | 210 | 292 | 326 | 417 | 664 | 681 | 675 | 501 | |
Total Expenditure | -168 | -170 | -176 | -250 | -282 | -362 | -521 | -561 | -566 | -419 | |
PBIDT | 29 | 30 | 33 | 42 | 44 | 55 | 143 | 120 | 109 | 82 | |
Interest | -8 | -8 | -8 | -8 | -8 | -7 | -8 | -13 | -23 | -31 | |
Depreciation | -9 | -9 | -11 | -11 | -11 | -12 | -16 | -18 | -27 | -28 | |
Taxation | -5 | -5 | -6 | -8 | -8 | -11 | -36 | -18 | -15 | -2 | |
Exceptional Items | |||||||||||
PAT | 8 | 8 | 8 | 15 | 16 | 25 | 83 | 71 | 43 | 21 | |
Adjusted EPS | 3 | 3 | 3 | 6 | 6 | 9 | 30 | 26 | 16 | 8 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 17 | 28 | 25 | 22 | 17 | 25 | 21 | 44 | 1 | -22 | |
Cash Fr. Inv. | -9 | -17 | -31 | -8 | -12 | -13 | -28 | -109 | -75 | -93 | |
Cash Fr. Finan. | -8 | -11 | 5 | -13 | 2 | -13 | 3 | 75 | 62 | 132 | |
Net Change | 1 | 0 | 0 | 0 | 7 | 0 | -4 | 10 | -12 | 16 | |
Cash & Cash Eqvt | 1 | 1 | 0 | 1 | 8 | 8 | 4 | 14 | 2 | 18 |
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations Sajankumar R. Bajajᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ |
Fri, 12 Apr 2024
Spurt in Volume Significant increase in volume has been observed in Bajaj Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
Thu, 28 Mar 2024
Trading Window-XBRL Bajaj Healthcare Limited has informed the Exchange about Closure of Trading Window |
Thu, 25 Apr 2024 |
High Increase in 1 Month |
High Decrease in 6 Months |
MFI Bearish |
CCI Overbought Zone |
Close Above Last Week High |